United States Contract Pharmaceutical Packaging Market to Reach US$ 7.97 Billion by 2032 | Top Companies - Catalent Pharma Solutions, Aphena Pharma Solutions, ROPACK INC

Leander, Texas and Tokyo, Japan - Jan.14.2026
As per DataM intelligence research report "Contract Pharmaceutical Packaging Market Size reached US$ 15.21 billion in 2024 and is expected to reach US$ 26.59 billion by 2032, growing with a CAGR of 7.23% during the forecast period 2025-2032."

The contract pharmaceutical packaging market is growing as outsourcing solutions improve efficiency, compliance, and speed-to-market. Innovations in automated packaging, serialization, and sustainable materials enhance product safety and operational efficiency. Increasing pharmaceutical production and global drug demand are fueling market expansion.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/contract-pharmaceutical-packaging-market?prasad

Contract Pharmaceutical Packaging Market: Competitive Intelligence
Catalent Pharma Solutions, Aphena Pharma Solutions, ROPACK INC, Wasdell Packaging Group, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer CentreSource

In the Contract Pharmaceutical Packaging Market, Catalent Pharma Solutions, Aphena Pharma Solutions, ROPACK INC, Wasdell Packaging Group, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, and Pfizer CentreSource together represent a robust ecosystem that enables pharmaceutical companies to scale, diversify, and optimize their packaging operations with quality and compliance at the forefront. These organizations provide end‐to‐end packaging services-including primary and secondary packaging, serialization, cold‐chain solutions, and regulatory support-that help manufacturers meet stringent global standards while addressing complex supply chain demands. Their capabilities support drug safety, traceability, and market readiness across various dosage forms such as injectables, oral solids, and biologics, which are critical in today's increasingly regulated landscape. By aligning advanced packaging technology with flexible execution models, they allow innovators and generics producers alike to accelerate time‐to‐market and mitigate operational risk. Together, they enhance the Contract Pharmaceutical Packaging Market's ability to sustain high‐quality output while adapting to evolving regulatory, logistical, and product‐specific challenges.

Individually and collectively, these companies' strengths reinforce competitive advantage and service depth within the Contract Pharmaceutical Packaging Market by blending engineering expertise, global scale, and regulatory proficiency. Catalent Pharma Solutions and Baxter BioPharma Solutions bring deep experience in complex biologics and sterile packaging, supporting high‐value product formats with rigorous quality frameworks. Aphena Pharma Solutions and AbbVie Contract Manufacturing extend robust technical packaging services that integrate serialization, cold‐chain logistics, and compliance management to meet demanding client requirements. ROPACK INC and Wasdell Packaging Group specialize in precision and innovation across primary, secondary, and specialized packaging applications, enhancing product protection and brand differentiation. Pfizer CentreSource adds substantial manufacturing and packaging scale, supporting large‐volume needs with established quality systems and global distribution alignment. Together, these firms deliver a suite of complementary strengths that empower pharmaceutical sponsors to focus on core R&D while relying on trusted partners to handle critical packaging functions-and in doing so, they drive growth, reliability, and innovation across the Contract Pharmaceutical Packaging Market.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/contract-pharmaceutical-packaging-market?prasad

United States: Recent Industry Developments

✅ In January 2026, Catalent expanded automated contract pharmaceutical packaging lines with robotics, AI quality inspection, and automated serialization tracking to support high‐volume sterile and solid dose products with improved compliance and reduced lead times.

✅ In November 2025, WestRock invested $60 million in advanced automated labeling, inspection, and packaging systems for contract pharma clients, enabling real‐time data integration and reducing manual rework across packaging operations.

✅ In August 2025, PCI Pharma Services deployed robotic packaging and AI‐driven vision inspection across multiple sites, automating blistering, labeling, and serialization to ensure accurate compliance for global supply chains.

✅ In June 2025, Sharp Packaging Services implemented automated end‐to‐end pharmaceutical packaging platforms, including robotics for filling, labeling, and sealing with integrated quality control and reporting tools.

Japan: Recent Industry Developments

✅ In January 2026, Nipro Corporation deployed automated contract pharmaceutical packaging systems with AI‐enhanced vision inspection, supported by $30 million investment, improving accuracy, compliance, and throughput for CDMO clients.

✅ In October 2025, Mitsubishi Chemical Packaging implemented robotic labeling and serialization platforms with real‐time quality analytics to enable faster, compliant contract packaging for domestic and export markets.

✅ In July 2025, Fujifilm Healthcare introduced automated packaging lines for pharma partners, integrating robotics and data monitoring to enhance consistency and reduce human error across batch operations.

✅ In April 2025, Olympus Corporation piloted automated inspection and packaging workflows for sensitive medical products, combining robotics and AI to ensure high‐precision results and traceability.

Segment Covered in the Contract Pharmaceutical Packaging Market:
By Type
The market is segmented into blister packaging (38%), bottle & container packaging (30%), tube packaging (12%), vial & ampoule packaging (10%), and other packaging types (10%). Blister packaging dominates due to its widespread use in oral solid dosage forms, child-resistant designs, and cost-effectiveness. Bottles and containers are widely used for liquids, syrups, and capsules, while tube and vial/ampoule packaging are preferred for specialty drugs and injectable formulations. Other packaging types include pre-filled syringes, sachets, and medical pouches.

By Raw Material
Raw materials include plastic (42%), glass (28%), aluminum (18%), and other materials (12%). Plastic dominates due to its lightweight, versatility, and compatibility with various drug forms. Glass is widely used for injectable and high-value drugs due to stability and inert properties. Aluminum is commonly applied in blister foils and specialty packaging, while other materials include paper-based, composite, and biodegradable options.

By Application
Applications include oral solids (42%), liquids & syrups (25%), injectables (20%), topicals (8%), and other applications (5%). Oral solid dosage forms dominate due to global high consumption of tablets and capsules. Liquids and injectables are growing with increasing prevalence of chronic and specialty therapies. Topicals and other dosage forms cater to niche applications such as dermatology, ophthalmology, and veterinary medicines.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=contract-pharmaceutical-packaging-market

Regional Analysis
North America - 35% Share
North America leads due to high pharmaceutical outsourcing, regulatory compliance requirements, and advanced packaging technologies supporting drug stability and patient safety.

Europe - 28% Share
Europe holds a significant share, driven by a strong pharmaceutical manufacturing base, contract service adoption, and demand for specialty packaging for biologics and high-value drugs.

Asia Pacific - 25% Share
Asia Pacific is witnessing rapid growth due to increasing pharmaceutical manufacturing, rising contract packaging outsourcing, and supportive regulatory frameworks in India, China, and Japan.

Latin America - 7% Share
Latin America shows steady growth, supported by emerging pharmaceutical markets, growing healthcare infrastructure, and increasing demand for packaged medicines.

Middle East & Africa - 5% Share
The Middle East & Africa market is emerging with growth driven by increasing pharmaceutical production, healthcare expansion, and rising adoption of outsourced packaging solutions.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.